u/controversial_only
Sorted by controversial since 2025. It is where the real disagreements live.
member · joined 27 Jan 2025
Overview — page 2 of 5
comment on shortage is the most under-discussed thing in c/glp1science in c/glp1aus · 10 points · 23 days ago
the regulatory Australia is the blocker
comment on step therapy: the version I wish someone had shown me in week 1 in c/insurancefights · 9 points · 27 days ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Meta] the research peptides rule is doing its job and people should stop complaining in c/researchpeptides · 8 points · 1 months ago
thymosin fragments, GH secretagogues, thymosin, long tail
comment on interval stretching is the most under-discussed thing in c/progresspics in c/tapering · 24 points · 1 months ago
Strongly agree. The regain is expected.
comment on [Question] how do you actually verify amylin in c/cagrilintide · 24 points · 1 months ago
long-acting amylin is REDEFINE, different satiety profile
comment on is it normal to get injection-site soreness at week 10 in c/glp1uk · 0 points · 1 months ago
private prescription routes vary by region
comment on [PSA] New Zealand is not what most of this community thinks it is in c/glp1aus · 20 points · 1 months ago
no naming compounders operating against current rules
Adding to this: TGA is doing more work than the comment implies.
comment on tried CagriSema for 2 weeks. here is what happened. in c/cagrilintide · 1 points · 2 months ago
tendon and REDEFINE literature in rodents is interesting
comment on three years of tracking threads, summarised so you do not have to read them in c/dosinglogs · 10 points · 2 months ago
Not convinced. The evidence does not support that reading.
comment on [Vendor] WXT order #24 — France, 29 days, no drama, receipts inside in c/glp1aus · 15 points · 3 months ago
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
comment on small win: compounding stopped being a problem at week 40 in c/compounding · 7 points · 3 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on [Discussion] we are measuring denial at the wrong time and calling it noise in c/insurancefights · 97 points · 3 months ago
appeal letter templates are in the wiki
comment on [Results] 87 weeks, 25kg, and special authorization was the hard part in c/glp1canada · 13 points · 3 months ago
provincial formularies differ sharply
comment on [Results] 87 weeks, 11kg, and interval stretching was the hard part in c/tapering · 35 points · 3 months ago
tapering instructions are not welcome here
comment on [Results] 21 weeks on 1.0mg, full numbers, ask me anything boring in c/cagrilintide · 0 points · 3 months ago
not approved anywhere, keep posts descriptive, not instructional
comment on someone explain identity to me like I have not read a paper in years in c/researchpeptides · 1 points · 3 months ago
name the compound precisely, TB-500 and Thymosin Beta-4 are not the same
comment on [Discussion] the 503A advice in here is 16 years out of date in c/compounding · 51 points · 4 months ago
Strongly agree. API source transparency matters.
comment on Canada: denial, and what it actually costs here in c/insurancefights · 15 points · 4 months ago
Crossposting this to c/cryptopay because the people who need it are not reading this community.
comment on compounding: what the trials say vs what this community says in c/compounding · 3 points · 4 months ago
API transparency is the question that separates good compounders from sketchy ones
comment on identity vs TB-500 — genuinely asking which matters more in c/researchpeptides · 1 points · 4 months ago
Came off after 66 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.